Slate Medicines

biotechRaleighseries_a

Raleigh biotech advancing anti-PACAP antibody therapies for the prevention of migraine and other headache disorders.

At a glance

HQ: Raleigh
Sector: Biotech
Stage: Series A
Total raised: $130M
Last round: Series A

This is the free preview.

The full profile is for members: founders, funding history, investor connections, and recent signals. Accounts are free; I review every request, usually within 48 hours.